287 related articles for article (PubMed ID: 2579437)
21. The pharmacology of heparin prophylaxis.
MacHarg MA; Becht JL
J Am Vet Med Assoc; 1983 Jul; 183(1):129-30. PubMed ID: 6874519
[No Abstract] [Full Text] [Related]
22. In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169).
Walenga JM; Fareed J; Hoppensteadt DA
Semin Thromb Hemost; 1985 Jan; 11(1):17-25. PubMed ID: 3883497
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
Pletcher CH; Cunningham M; Nelsestuen GL
Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacology of heparin].
Hoffmann A; Markwardt F
Z Gesamte Inn Med; 1979 Jan; 34(1):3-8. PubMed ID: 373277
[TBL] [Abstract][Full Text] [Related]
25. [Heparin anticoagulant activity: new knowledge and future prospects].
Camici M; Giusti C; Evangelisti L
Recenti Prog Med; 1991 Apr; 82(4):209-18. PubMed ID: 1857840
[TBL] [Abstract][Full Text] [Related]
26. An investigation of the functional role of the carboxylic groups of heparin. Affinity for antithrombin III and anti-Xa activity of selectively carboxyl esterified heparin.
Mardiguian J; Trillou M
Semin Thromb Hemost; 1985 Jan; 11(1):34-6. PubMed ID: 3975640
[No Abstract] [Full Text] [Related]
27. The characteristics of anticoagulation by covalently immobilized heparin.
Miura Y; Aoyagi S; Kusada Y; Miyamoto K
J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
[TBL] [Abstract][Full Text] [Related]
28. [Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity].
Zhang L; Zhang G
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):309-12, 340. PubMed ID: 12080632
[TBL] [Abstract][Full Text] [Related]
29. Heparin and low-molecular-weight heparin.
Gray E; Mulloy B; Barrowcliffe TW
Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
[TBL] [Abstract][Full Text] [Related]
30. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
Scully MF; Kakkar VV
Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
[TBL] [Abstract][Full Text] [Related]
31. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
Hirsh J
Haemostasis; 1986; 16(2):82-6. PubMed ID: 3710297
[TBL] [Abstract][Full Text] [Related]
32. Heparin-induced thrombocytopenia and pentosan polysulfate: treatment with a low molecular weight heparin despite in vitro platelet aggregation.
Vitoux JF; Roncato M; Hourdebaigt P; Aiach M; Fiessinger JN
Thromb Haemost; 1986 Apr; 55(2):294-5. PubMed ID: 2424119
[No Abstract] [Full Text] [Related]
33. [The role of heparin in current therapy of thrombotic disease].
Komarnicki M
Pol Arch Med Wewn; 1982 Apr; 67(4):183-7. PubMed ID: 6752906
[No Abstract] [Full Text] [Related]
34. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B
Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589
[No Abstract] [Full Text] [Related]
35. A primate model (Macaca mulatta) to study the pharmacokinetics of heparin and its fractions.
Fareed J; Kumar A; Rock A; Walenga JM; Davis P
Semin Thromb Hemost; 1985 Apr; 11(2):138-54. PubMed ID: 4035364
[TBL] [Abstract][Full Text] [Related]
36. Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA
Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
[TBL] [Abstract][Full Text] [Related]
37. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
[TBL] [Abstract][Full Text] [Related]
38. Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
Messmore HL; Griffin B; Koza M; Seghatchian J; Fareed J; Coyne E
Semin Thromb Hemost; 1991; 17 Suppl 1():57-9. PubMed ID: 1712512
[TBL] [Abstract][Full Text] [Related]
39. [The determination of heparin].
Aiach M
Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
[No Abstract] [Full Text] [Related]
40. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
